Author

Jeffrey I. Everitt

Duke Medical CenterORCID 0000-0003-0273-6284Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Christopher M. CounteriD· 1 shared Özgün Le RouxiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christopher M. CounterORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyPLoS ONEPeer-reviewedMar 28, 2024

p53 dosage impedes KrasG12D- and KrasQ61R-mediated tumorigenesis

Özgün Le Roux, Jeffrey I. Everitt, Christopher M. Counter

The paper shows that increasing p53 dosage reduces tumor number and grade across multiple organs, regardless of Kras mutation type, and extends lifespan in a KrasG12D model.

3 citations

mouseexperimental assay

𝕏 PostBluesky